ITERUM THERAPEUTICS PLC

ITRMF

0.00010.00% ( 0.0000 )

Delay Trading: Nov 3, 09:30:00 (EDT)

Current ValuationThe current P/E ratio is 0.00, within the reasonable range, cheaper than 33.12% of the time in the past 1 years, and the industry ranks 62/258, the industry Median -1.07.

-0xP/E

Stock price$0.00

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

03876114152

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAYZFUSBayer Aktiengesellschaft	-27.19x	--	$54.78B
BAYRYUSBayer	-27.21x	--	$54.82B
VTRSUSViatris	-52.21x	107.68%	$21.44B
ELANUSElanco Animal Health	-60.51x	130.52%	$12.04B
ABVXUSAbivax SA	-15.92x	22.99%	$7.40B
AXSMUSAxsome Therap	-45.29x	31.15%	$7.12B
CURLFUSCuraleaf Holdings, Inc.	-134.77x	--	$7.01B
VREOFUSVIREO GROWTH INC	-104.17x	--	$6.99B
BLTEUSBelite Bio	-60.46x	29.87%	$6.19B
MANEUSVeraDermics	-51.89x	97.44%	$5.41B
DFTXUSDefinium Therapeutics	-12.33x	54.55%	$4.36B
EWTXUSEdgewise Therapeutics	-20.99x	187.50%	$4.14B
AMLXUSAmylyx Pharmaceuticals	-23.14x	1.76%	$3.52B
ELVNUSEnliven Therapeutics	-30.87x	5.59%	$3.27B
TARSUSTarsus Pharmaceuticals	-69.23x	345.28%	$3.22B
RGCUSRegencell Bioscience	-266.33x	--	$3.12B
BHCUSBausch Health	-3.57x	511.90%	$3.00B
MBXUSMBX Biosciences	-25.12x	31.12%	$2.62B
SUPNUSSupernus Pharma	-55.56x	77.94%	$2.44B
PHVSUSPharvaris BV	-11.88x	10.43%	$2.35B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.